glp-1 agonist gila monster The system that turned venom into drugs is now being dismantled through budget cuts for scientific research, Jeff Coller writes. “Less support for scientists means strange questions no one 🦎 One of the world's

Description

A randomised controlled trial in 1,897 individuals living with type 2 diabetes compared the impact of three doses of tirzepatide (5mg, 10mg, and 15mg) compared to a once-weekly injection of 1mg semaglutide (Ozempic) on blood sugar levels

Our guide on how to inject GLP-1 peptides covers the technique in full detail with illustrations

Optical coherence tomography Change in pRNFL thickness was not associated with the treatment group but with pRNFL thickness at baseline (M3: $\beta$= 0.32, 95% CI 0.41, 0.23

He lost 10 lbs, then gained 20

Conducted between June 2011 and March 2013 at 191 sites in 27 countries in Europe, North America, South America, Asia, and Australia this was a randomised, placebo-controlled trial designed to evaluate the efficacy and safety of 3mg liraglutide 'injected subcutaneously once daily, as an adjunct to a reduced-calorie diet and increased physical activity, for weight management in overweight or obese adults who did not have diabetes at baseline.' A total of 3,731 individuals participated in the trial, of whom 2,487 were assigned to lifestyle intervention plus liraglutide and 1,244 to lifestyle intervention with a placebo